Search

everythinglearnresearchcommunity

for

Search:↓

HPV genes and estradiol increase a cancer-related signaling pathway, which may be targeted for cervical cancer treatment.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

Inhibiting certain brain neurons may reduce pain and anxiety in trigeminal neuralgia.

Four drugs were found that could potentially treat COVID-19 by inhibiting the virus in lab tests.

OCT4B1 and SOX-2 levels are higher in Crohn's and ulcerative colitis patients, possibly aiding tissue repair.

Repurposing existing drugs and using micronutrients may effectively target cancer stem cells and improve cancer treatment.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

SOX11 and SOX4 help skin cells act like embryonic cells to heal wounds in mice.

Overexpressing COX-2 in mice skin reduces skin tumor development.

Dual TCR Treg cells are common in mouse tissues and vary by location.

ONO-3403 effectively reduces mouse skin tumor growth without side effects.

TMPRSS2 affects COVID-19 severity and treatment options.

Cepharanthine and tetrandrine show promise as COVID-19 drugs.

Blocking TRPV3 may help treat itch in dry skin conditions.

Thioredoxin reductase 1 does not affect glucocorticoid receptor activity in hair follicle cells.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

Researchers found several compounds that could potentially treat Zika virus.

DcR3 helps heal wounds and regrow hair by changing macrophages to a repair-focused type.

Mitochondrial Complex I reduces inflammation and increases bone breakdown by affecting certain immune cells.

The antibody 005-C04 blocks prolactin receptors, causing reversible infertility, impaired lactation, and hair regrowth in female mice.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.

The new cocrystal KET-PABA is a more effective and safe anti-inflammatory treatment for skin conditions in mice.

Finasteride reduces certain behaviors caused by D1-like receptor agonists but not by D2-like receptor agonists in mice.

ERG increases SOX9, promoting prostate cancer growth and invasion.

Suppressing ODC activity reduces tumor growth in hair follicles.

Germacrene analogs, especially 8-Hydroxy germacrene B, are more effective than germacrone at blocking a hormone-related enzyme and could help treat hair loss.

Dual TCR Treg cells are common in various mouse tissues and show diverse characteristics.

Adding a second method to PROTACs could improve cancer treatment.

CDK4/6 inhibitors affect safety and quality of life differently, requiring careful use.

RXRα is crucial for hair growth and skin cell function.